Form 8-K - Current report:
SEC Accession No. 0001193805-20-000412
Filing Date
2020-03-27
Accepted
2020-03-27 17:20:09
Documents
4
Period of Report
2020-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e619507_8k-at.htm 8-K 21056
2 e619507_ex5-1.htm EX-5.1 7923
3 e619507_ex10-1.htm EX-10.1 238532
4 GRAPHIC image_001.jpg GRAPHIC 2179
  Complete submission text file 0001193805-20-000412.txt   271811
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 20752944
SIC: 2834 Pharmaceutical Preparations